| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918098 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Incorporation of HT with concurrent 5FU/MMC had low treatment-related acute and late morbidity with few treatment breaks. However, the expected dosimetric benefit for hematological toxicity was not experienced clinically.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kurian Joseph, Yugmel Nijjar, Heather Warkentin, Dan Schiller, Keith Tankel, Nawaid Usmani, Diane Severin, Sunita Ghosh, Alasdair Syme, Tirath Nijjar, Karen Mulder, Corinne Doll, Clarence Wong, Colin Field,